|
Index of reports
> Cases resulting in other serious reactions (95)
> Cases with Hyponatraemia (8)
Below is the selection of adverse event reports related to Hydrochlorothiazide that includes cases resulting in other serious reactions where reactions include hyponatraemia.
Adverse event in female receiving Hydrochlorothiazide
Reported by a pharmacist from France on 2007-10-15
Patient: female
Adverse reactions / side effects: Confusional State, Hypersensitivity, Depersonalisation, Multiple Myeloma, Pyrexia, Hepatitis, Loss of Consciousness, Hypokinesia, Spinal Compression Fracture, Skin Lesion, Inappropriate Antidiuretic Hormone Secretion, Humerus Fracture, Back Pain, Phlebitis, Pain in Extremity, Musculoskeletal Pain, Hyponatraemia, Amnesia, Epilepsy, Spondylitis, Renal Failure, Respiratory Failure, Staphylococcal Infection, Sepsis, Blood Pressure Decreased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Depakene
Administration route: Oral
Indication: Facial Neuralgia
Start date: 2004-10-18
End date: 2004-11-01
Hydrochlorothiazide
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 1999-01-01
End date: 2004-11-01
Other drugs received by patient: Amlodipine; Irbesartan; Omeprazole; Domperidone; Nitrofurantoin; Nifedipine
Adverse event in female receiving Hydrochlorothiazide
Reported by a pharmacist from France on 2007-10-12
Patient: female
Adverse reactions / side effects: Confusional State, Hypersensitivity, Depersonalisation, Multiple Myeloma, Pyrexia, Hepatitis, Loss of Consciousness, Hypokinesia, Spinal Compression Fracture, Skin Lesion, Inappropriate Antidiuretic Hormone Secretion, Humerus Fracture, Back Pain, Phlebitis, Pain in Extremity, Musculoskeletal Pain, Hyponatraemia, Amnesia, Epilepsy, Spondylitis, Renal Failure, Respiratory Failure, Staphylococcal Infection, Sepsis, Blood Pressure Decreased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Depakene
Administration route: Oral
Indication: Facial Neuralgia
Start date: 2004-10-18
End date: 2004-11-01
Hydrochlorothiazide
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 1999-01-01
End date: 2004-11-01
Other drugs received by patient: Amlodipine; Irbesartan; Omeprazole; Domperidone; Nitrofurantoin; Nifedipine
Adverse event in female receiving Hydrochlorothiazide
Reported by a physician from Germany on 2007-10-08
Patient: female, weighing 75.0 kg (165.0 pounds)
Adverse reactions / side effects: Confusional State, Blood Bilirubin Increased, Blood Creatine Phosphokinase Increased, Aphasia, Cholestasis, Pulmonary Congestion, Liver Function Test Abnormal, Oedema, Thrombocytopenia, Blood Creatinine Increased, Hyponatraemia, Febrile Neutropenia, Staphylococcal Infection, Dehydration, Depressed Level of Consciousness, Asthenia, Hypertension
Adverse event resulted in: hospitalization
Suspect drug(s):
Hydrochlorothiazide
Dosage: daily dose:25mg
Administration route: Oral
Indication: Hypertension
Start date: 2007-03-01
End date: 2007-01-01
Ramipril
Dosage: daily dose:25mg
Administration route: Oral
Indication: Hypertension
Start date: 2007-03-01
End date: 2007-05-12
Sutent
Dosage: daily dose:50mg
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Start date: 2007-04-26
End date: 2007-05-12
Other drugs received by patient: ACE Inhibitor NOS; Bayotensin; Norvasc
Adverse event in 68 year old male receiving Hydrochlorothiazide
Reported by a individual with unspecified qualification from United States on 2007-07-25
Patient: 68 year old male, weighing 68.8 kg (151.4 pounds)
Adverse reactions / side effects: Hyponatraemia
Suspect drug(s):
Hydrochlorothiazide
Adverse event in 61 year old female receiving Hydrochlorothiazide
Reported by a consumer/non-health professional from United States on 2007-05-29
Patient: 61 year old female, weighing 65.3 kg (143.7 pounds)
Adverse reactions / side effects: Confusional State, Hypokalaemia, Fatigue, Vitreous Floaters, Dizziness, Thrombocytopenia, Thyroid Function Test Abnormal, Hepatic Cirrhosis, White Blood Cell Count Decreased, Nausea, Blood Chloride Decreased, Anaemia, Hypotension, Hyponatraemia, Bursitis, Haemoglobin Decreased, Arthralgia, Diarrhoea, Dehydration, Platelet Count Decreased, Neutropenia, Asthenia, Neutrophil Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Hypertension
End date: 2006-05-26
Hydrochlorothiazide
Dosage: drug reported as spironolactone aldactone/ hctz. strength reported as 25. frequency reported as 2/d.
Administration route: Oral
Indication: Hypertension
End date: 2006-05-26
Pegasys
Dosage: patient was off therapy for ten days.
Start date: 2006-04-26
Pegasys
End date: 2006-11-01
Pegasys
Start date: 2006-11-01
Pegasys
End date: 2007-02-01
Pegasys
Start date: 2007-02-01
Ribavirin
Dosage: frequency reported as 5/d. patient was off therapy for ten days.
Administration route: Oral
Start date: 2006-04-26
Ribavirin
Dosage: frequency reported as 5/d.
Administration route: Oral
Other drugs received by patient: Synthroid
Adverse event in 67 year old male receiving Hydrochlorothiazide
Reported by a individual with unspecified qualification from United States on 2007-02-20
Patient: 67 year old male, weighing 63.5 kg (139.7 pounds)
Adverse reactions / side effects: Hyponatraemia
Suspect drug(s):
Hydrochlorothiazide
Adverse event in 56 year old male receiving Hydrochlorothiazide
Reported by a individual with unspecified qualification from United States on 2007-02-20
Patient: 56 year old male, weighing 99.5 kg (218.9 pounds)
Adverse reactions / side effects: Chest Pain, Hyponatraemia, Hypokalaemia
Suspect drug(s):
Hydrochlorothiazide
Adverse event in receiving Hydrochlorothiazide
Reported by a physician from Netherlands on 2007-01-12
Patient:
Adverse reactions / side effects: Hyponatraemia, Hypokalaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 5 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2006-02-02
End date: 2006-07-21
Hydrochlorothiazide
Dosage: 25 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2006-02-02
End date: 2006-07-21
Septra
Administration route: Oral
Indication: Urinary Tract Infection
Start date: 2006-07-01
End date: 2006-07-21
Other drugs received by patient: Atenololum; Simvastatin; Calcium Carbonate; Fosamax
|
